Elon Musk in 2026: xAI at $500M ARR, Tesla Margins at 1.4 Percent

Tesla reported Q2 2026 revenue of $28.24 billion against an operating margin of 1.4 percent, the company's thinnest quarterly result in years, as capital expenditure surged 142 percent year-over-year to $5.8 billion directed at AI and robotics, per Tesla's Q2 2026 earnings release covered by Electrek. At the same time, xAI, now folded into SpaceXAI, generates an estimated $500 million in annualised recurring revenue against a combined valuation of $1.25 trillion.

xAI inside SpaceXAI: $42 billion raised, $500 million in ARR

Musk founded xAI in July 2023 and, within two and a half years, raised a total of $42 billion across multiple funding rounds. The final standalone close, a $20 billion Series E in January 2026 at a $230 billion valuation, was followed five weeks later by a full merger with SpaceX on February 2, 2026, creating a combined entity valued at $1.25 trillion, per ValueAddVC's analysis of the xAI valuation arc.

The AI arm now generates an estimated $500 million in annualised recurring revenue, driven primarily by Grok subscriptions and enterprise API access, per AI Business Weekly's xAI statistics tracker. Against $42 billion in total capital raised and a monthly burn rate of approximately $1 billion, that translates to roughly 1.2 cents in ARR for every dollar invested. The gap reflects xAI's heavy spending on the Colossus supercomputer cluster in Memphis and on building inference capacity at a scale designed to serve millions of Grok users globally. Inside SpaceXAI, AI workloads and Starlink's satellite connectivity infrastructure now share capital allocation decisions; the specific revenue split between the former SpaceX and xAI divisions has not been publicly disclosed. For more on xAI's hardware strategy and operating culture, see this analysis of the company's internal build approach.

Tesla: record revenue, profit under pressure

Tesla's Q2 2026 results showed both sides of Musk's resource allocation. Revenue of $28.24 billion rose 26 percent year-over-year and beat Wall Street's $25.55 billion consensus estimate. The profit picture diverged sharply: earnings per share came in at $0.33 against a consensus of $0.49, while operating income fell 57 percent year-over-year to $398 million, per the Tesla Q2 2026 press release. That compression placed operating margin at 1.4 percent.

Automotive gross margin excluding regulatory credits fell to 16.3 percent in Q2, down from 19.2 percent in Q1 2026. The energy segment's gross margin dropped from 39.5 percent to 20.4 percent. Capital expenditure surged to $5.8 billion (+142 percent year-over-year), producing negative free cash flow of negative $1.1 billion. Tesla attributed the CapEx increase to accelerated AI, robotics, and autonomous systems infrastructure investment, per Electrek's earnings report. TSLA shares fell 14.52 percent on July 23 as investors responded to the EPS miss and margin compression rather than the revenue beat.

Starlink, X, and Neuralink: the rest of the portfolio

Starlink is the most cash-generative arm of the complex. In Q1 2026, it produced $3.26 billion in revenue and $1.19 billion in operating income, implying a 36.5 percent segment margin, per TradingKey's analysis of the SpaceX S-1 filing. The subscriber base stood at 10.3 million across 155 countries as of March 31, 2026. Annualised, the Q1 run rate implies roughly $13 billion in Starlink revenue, within total SpaceX revenue of approximately $18.2 billion for the year. SpaceX completed its public listing in 2026 under the ticker SPCX, with the stock trading below its $135 IPO price by mid-July.

X, formerly Twitter, generated $752 million in Q1 2026 revenue, up 17 percent year-over-year. For the full 2026 calendar year, eMarketer projects X's advertising revenue at $2.46 billion, still less than half of Twitter's $5.1 billion advertising peak in 2022, per Business of Apps. Subscription revenue runs at approximately $1 billion annualised, bringing total estimated 2026 revenue to around $3.5 billion. Musk has not disclosed a specific revenue target for X in 2026.

Neuralink is the pre-revenue arm. Twelve patients worldwide had received implants as of September 2025. In June 2025, the company raised $650 million in new funding. Neuralink has announced plans for high-volume production of its brain-computer interface device in 2026, alongside fully automated surgical procedures, following FDA clearance, per Republic World's coverage of the post-FDA clearance roadmap. No revenue figures have been disclosed.

What it means

The mid-2026 picture is a portfolio running three distinct financial profiles simultaneously. SpaceXAI is in deep investment mode, consuming roughly $1 billion per month in compute and infrastructure while generating $500 million in annualised revenue. Tesla is channelling automotive cash flow into AI and robotics CapEx at a pace that produced negative free cash flow in Q2 and compressed operating margin to 1.4 percent. Starlink is the financial bridge: generating roughly $1.19 billion in operating income per quarter at a 36.5 percent segment margin, it is the arm currently funding the others. X is recovering slowly from its post-acquisition revenue trough toward a $3.5 billion annualised baseline, and Neuralink remains years from material revenue. The overall architecture functions less as a diversified holding company and more as a set of interlocking bets on AI infrastructure, compute, and connectivity, funded in the near term by a satellite business that Musk did not found but has made structurally central to everything else he is building.

Sources

• Electrek: Tesla (TSLA) Q2 2026 financial results
• StockTitan: Tesla releases second quarter 2026 financial results (Tesla IR)
• ValueAddVC: xAI Valuation 2026: $230B Series E, $1.25T Combined With SpaceX
• AI Business Weekly: xAI Statistics 2026: Valuation, Revenue and Grok Data
• TradingKey: SpaceX 2026 Profit and Revenue Breakdown, Starlink vs Launch vs Grok
• Business of Apps: X (Twitter) Revenue and Usage Statistics 2026
• Republic World: Neuralink Plans High-Volume Brain Implant Rollout in 2026

Editorial standards: every claim is sourced. Tips: [email protected]